4//SEC Filing
Anson Management GP LLC 4
Accession 0000921895-23-002374
CIK 0001262104other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 7:32 PM ET
Size
23.7 KB
Accession
0000921895-23-002374
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
Anson Advisors Inc.
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+143,200$1,002,400→ 1,057,388 total(indirect: See footnotes) - Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+35,800$250,600→ 1,093,188 total(indirect: See footnotes) - Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−358→ 6,710 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (35,800 underlying) - Expiration
Put Option (obligation to buy)
2023-10-20−6,710→ 0 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (671,000 underlying) - Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−1,432→ 7,068 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (143,200 underlying)
Nathoo Amin
10% Owner
Transactions
- Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−358→ 6,710 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (35,800 underlying) - Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+143,200$1,002,400→ 1,057,388 total(indirect: See footnotes) - Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+35,800$250,600→ 1,093,188 total(indirect: See footnotes) - Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−1,432→ 7,068 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (143,200 underlying) - Expiration
Put Option (obligation to buy)
2023-10-20−6,710→ 0 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (671,000 underlying)
Kassam Moez
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+143,200$1,002,400→ 1,057,388 total(indirect: See footnotes) - Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−358→ 6,710 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (35,800 underlying) - Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+35,800$250,600→ 1,093,188 total(indirect: See footnotes) - Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−1,432→ 7,068 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (143,200 underlying) - Expiration
Put Option (obligation to buy)
2023-10-20−6,710→ 0 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (671,000 underlying)
Anson Management GP LLC
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+143,200$1,002,400→ 1,057,388 total(indirect: See footnotes) - Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+35,800$250,600→ 1,093,188 total(indirect: See footnotes) - Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−1,432→ 7,068 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (143,200 underlying) - Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−358→ 6,710 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (35,800 underlying) - Expiration
Put Option (obligation to buy)
2023-10-20−6,710→ 0 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (671,000 underlying)
Anson Funds Management LP
10% Owner
Transactions
- Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−1,432→ 7,068 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (143,200 underlying) - Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−358→ 6,710 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (35,800 underlying) - Expiration
Put Option (obligation to buy)
2023-10-20−6,710→ 0 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (671,000 underlying) - Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+143,200$1,002,400→ 1,057,388 total(indirect: See footnotes) - Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+35,800$250,600→ 1,093,188 total(indirect: See footnotes)
Winson Bruce Ross
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+35,800$250,600→ 1,093,188 total(indirect: See footnotes) - Exercise of In-Money
Common Stock
2023-10-20$7.00/sh+143,200$1,002,400→ 1,057,388 total(indirect: See footnotes) - Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−1,432→ 7,068 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (143,200 underlying) - Exercise of In-Money
Put Option (obligation to buy)
2023-10-20−358→ 6,710 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (35,800 underlying) - Expiration
Put Option (obligation to buy)
2023-10-20−6,710→ 0 total(indirect: See footnotes)Exercise: $7.00From: 2023-09-22Exp: 2023-10-20→ Common Stock (671,000 underlying)
Footnotes (3)
- [F1]The filing of this Form 4 shall not be construed as an admission that Anson Funds Management LP ("Anson"), Anson Management GP LLC, the general partner of Anson ("Anson GP"), Bruce R. Winson, the manager of Anson GP, Anson Advisors Inc. ("Anson Advisors"), Amin Nathoo, a director of Anson Advisors, or Moez Kassam, a director of Anson Advisors, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the securities of MEI Pharma, Inc. (the "Issuer") purchased by Anson Investments Master Fund LP, Anson East Master Fund LP and Anson Opportunities Master Fund LP (collectively, the "Funds"), each advised by Anson and Anson Advisors.
- [F2]Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
- [F3]Anson and Anson Advisors hold indirectly the securities of the Issuer through the Funds, for which Anson and Anson Advisors are the Investment Advisors. Anson GP and Bruce R. Winson report the securities held indirectly by the Funds because, as the general partner of Anson and the manager of Anson GP, respectively, at the time of purchase, they controlled the disposition and voting of the securities. Mr. Nathoo and Mr. Kassam report the securities held indirectly by the Funds because, as the directors of Anson Advisors, at the time of purchase, they controlled the disposition and voting of the securities.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeother
IncorporatedTX
Related Parties
1- filerCIK 0001491073
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 7:32 PM ET
- Size
- 23.7 KB